Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Receptor Agonist
100%
Behavioral Sensitivity
100%
Phenethylamines
100%
Metabotropic Glutamate Receptor 2/3
100%
Hallucinogens
100%
MGlu2/3 Receptor
50%
Behavioral Effects
25%
Discriminative Stimulus
25%
Psychotomimetic
25%
Group II Metabotropic Glutamate Receptors
25%
Dosing Regimen
12%
Mouse Model
12%
Glutamatergic Neurotransmission
12%
Behavioral Activity
12%
Schizophrenic
12%
Negative Symptoms
12%
Phencyclidine
12%
Selective Agonist
12%
Chronic Study
12%
Positive Symptoms
12%
CD-1 Mice
12%
In Vivo Activity
12%
Repeated Dosing
12%
Genetic Strategies
12%
5-HT2C Receptor
12%
Lysergic Acid Diethylamide
12%
MGlu2/3 Receptor Agonist
12%
Glutamatergic Transmission
12%
Pharmacological Strategies
12%
Drug Discrimination
12%
Hyperlocomotion
12%
LY379268
12%
5-HT2A Receptor Antagonist
12%
Dynamic Action
12%
M100907
12%
Head Twitch Response
12%
Discrimination Training
12%
Dose-dependent
12%
Neuroscience
Receptor Agonists
100%
Hallucinogen
100%
Phenethylamine
100%
Glutamic Acid
100%
Receptor
44%
Behavioral Effect
22%
Psychotomimetic
22%
In Vivo
11%
Phencyclidine
11%
Metabotropic Glutamate Receptor
11%
Lysergic Acid Diethylamide
11%
Drug Discrimination
11%
5-HT2A Receptor
11%
Receptor Agonist
11%
Agonist
11%
Negative Syndrome
11%
Glutamate Receptor
11%
Receptor Antagonist
11%
Positive Syndrome
11%
4 Amino 2 oxabicyclo[3.1.0]hexane 4,6 Dicarboxylic Acid
11%
Metabotropic Receptor
11%
Synaptic Transmission
11%
Genetics
11%